Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06898996 | RECRUITING | Colorectal Cancer

FITting Non-invasive Tests in Lynch Syndrome Surveillance
Sponsor:

University of Chicago

Brief Summary:

The purpose of this clinical study is to evaluate the accuracy of the fecal immunochemical test (FIT) in comparison to colonoscopy in patients with Lynch Syndrome (LS) who are undergoing colonoscopy surveillance.

Condition or disease

Colorectal Cancer

Intervention/treatment

Fecal immunochemical test

Detailed Description:

Lynch syndrome (LS), the most common inherited cause of colorectal cancer (CRC) affecting about 1.2 million Americans. Colonoscopy starting early in adulthood and repeated yearly or biennially is the only recommended surveillance strategy which translates into about 25-50 lifetime colonoscopies. This intensive colonoscopy surveillance is not ideal because CRC risk varies widely by LS gene and age, colonoscopies are invasive, costly, and not readily accessible to all patients, and adherence is suboptimal. This clinical study will examine the performance of the fecal immunochemical test (FIT) in Lynch Syndrome (LS) patients undergoing colonoscopy surveillance. In addition to assessing the characteristics of the FIT test, such as specificity, sensitivity, and both negative and positive predictive values, the study will also explore LS patients' attitudes toward and acceptability of non-invasive testing methods. This comprehensive approach aims to provide insights into both the diagnostic effectiveness of FIT and the potential for improving patient adherence to screening protocols through less invasive options.

Study Type : OBSERVATIONAL
Estimated Enrollment : 400 participants
Official Title : FITting Non-invasive Testing Into Lynch Syndrome Colorectal Cancer Surveillance: a Multi-center, Prospective Study
Actual Study Start Date : 2025-07-10
Estimated Primary Completion Date : 2029-03-01
Estimated Study Completion Date : 2029-07-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 20 Years to 75 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Have a diagnosis of LS with a confirmed pathogenic variant in MLH1, MSH2, MSH6, PMS2 or EPCAM genes.
  • * Aged 20 - 75 years (for those with pathogenic variants in MLH1, MSH2, and EPCAM)
  • * Aged 30 - 75 years (for those with pathogenic variants in PMS2 or MSH6).
  • * Have an upcoming standard of care (SOC) colonoscopy appointment in line with standard LS surveillance guidelines (NCCN).
  • * Willing to sign informed consent, collect stools samples and complete surveys
Exclusion Criteria
  • * Individuals who have not proceeded with genetic testing and therefore are not known to have LS, despite family history and/or criteria for testing.
  • * Individuals who have previously undergone a subtotal or total colectomy.
  • * Newly diagnosed Lynch Syndrome patients \< 20 years old with a pathogenic variant in MLH1, MSH2 or EPCAM, MSH6 or PMS2.
  • * Newly diagnosed Lynch Syndrome patients \< 30 years old with a pathogenic variant in MSH6 or PMS2.
  • * Individuals who are pregnant.
  • * Individuals with inflammatory bowel disease or active malignancy.
  • * Individuals not willing or able to sign informed consent.
FITting Non-invasive Tests in Lynch Syndrome Surveillance

Location Details

NCT06898996

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

United States, Illinois

The University of Chicago Medical Center

Chicago, Illinois, United States, 60639

RECRUITING

United States, road cancer

University of Michigan

Ann Arbor, road cancer, United States, 48109

RECRUITING

United States, New York

Columbia University

New York, New York, United States, 10032